DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME6ZR89

Market Closed - Börse Stuttgart 15:26:36 2024-06-12 EDT
0.021 EUR -38.24% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-92.76%
1 month-93.82%
Date Price Change
24-06-12 0.021 -38.24%
24-06-11 0.034 -46.03%
24-06-10 0.063 -52.63%
24-06-07 0.133 -21.30%
24-06-06 0.169 -9.63%

Delayed Quote Börse Stuttgart

Last update June 12, 2024 at 03:26 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME6ZR8
ISINDE000ME6ZR89
Date issued 2024-01-16
Strike 75 $
Maturity 2024-06-21 (9 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.46
Lowest since issue 0.021

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
61.69 USD
Average target price
88.55 USD
Spread / Average Target
+43.55%
Consensus